The United Arab Emirates has taken a major step in healthcare innovation. The country has moved closer to creating an AI cancer drug with a new drug candidate called ISM0387. The Emirates Drug Establishment announced this progress with Insilico Medicine.
This drug is fully designed using artificial intelligence. It aims to help fight cancer, especially hard-to-treat brain cancers. These cancers often do not respond well to normal treatments. The new compound shows strong early promise in fighting such diseases.
ISM0387 works by targeting a cancer-related enzyme called PRMT5. It uses a method called synthetic lethality. This method helps attack cancer cells with a specific gene weakness. It also helps protect healthy cells from damage.
The drug focuses on solid tumours, especially aggressive brain tumours. Early results show strong activity against tumour growth. This gives hope for future cancer treatment options. Researchers also say it may help in other brain related diseases.
Insilico Medicine developed ISM0387 using its advanced Chemistry42 system. This system uses more than 40 AI models. It studies large biological and chemical data sets. It then creates and tests possible drug molecules.
The AI system helped complete early drug discovery very fast. It generated and tested more than 90 molecules in around six months. Normal drug discovery usually takes more than four years for this stage.
In animal studies, ISM0387 showed clear results. A daily dose helped reduce tumour size over 20 days. The results also showed strong dose based response. Higher doses showed better tumour control.
Another important result shows that ISM0387 can cross the blood brain barrier. This is very important for treating brain cancer. Many drugs fail because they cannot reach the brain properly.
The Emirates Drug Establishment said this project strengthens UAE leadership in medical innovation. Officials stated that this achievement supports the country’s goal to grow in global biotech research. It also builds strong local scientific talent.
The next step for ISM0387 will be clinical trials in humans. Researchers will study safety and effectiveness in detail. This stage will take more time before final approval.
Experts believe this AI cancer drug UAE project can change drug discovery speed. It may reduce years of research into months in the future. It also shows how AI drug discovery can support faster medical progress.
This development places UAE in a stronger position in global healthcare research. It also shows how AI can support new treatments for serious diseases like cancer.
Also Read: UAE Ranks High in AI Momentum, Investors Move Beyond Traditional Research